IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Theseus Pharmaceuticals I

CUSIP: 88369M101 | 119 institutional holders

Quarters

Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2024

Goldman Sachs Group Inc30,366
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Goldman Sachs Group Inc
30,366$00.0%CoreMediumNew York, NY2024-05-15